Prokidney (PROK) EBT (2021 - 2026)

Prokidney (PROK) has reported EBT for 6 consecutive years, with -$46.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 28.57% year-over-year to -$46.4 million in Q2 2026; TTM through Jun 2026 was -$166.8 million, a 1.91% decrease from a year earlier, with the FY2025 full-year figure at -$151.2 million, up 7.77% from the prior year.
• EBT was -$46.4 million for Q2 2026 at Prokidney, down from -$42.6 million in the prior quarter.
• Over five years, EBT peaked at -$18.9 million in Q4 2023 and troughed at -$66.5 million in Q1 2022.
• A 5-year average of -$37.8 million and a median of -$36.7 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT plunged 14620879.02% in 2022 and soared 46.47% in 2023, its largest moves.
• Over 5 years, EBT stood at -$25.8 million in 2022, then grew by 26.72% to -$18.9 million in 2023, then sank by 147.09% to -$46.8 million in 2024, then advanced by 9.29% to -$42.4 million in 2025, then dropped by 9.42% to -$46.4 million in 2026.
• The last three EBT figures came in at -$46.4 million (Q2 2026), -$42.6 million (Q1 2026), and -$42.4 million (Q4 2025), per Business Quant data.